Krzesicki R F, Hatfield C A, Bienkowski M J, McGuire J C, Winterrowd G E, Chapman D L, Berger A E, McEwan R N, Carter D B, Chosay J G
Department of Hypersensitivity Diseases Research, Upjohn Laboratory, Kalamazoo, MI 49001.
J Immunol. 1993 May 1;150(9):4008-18.
The IL-1R antagonist protein (IRAP) is a competitive inhibitor of IL-1, which is predominantly synthesized by monocytes. We show that this molecule is also expressed in human synovial fibroblasts and dermal fibroblasts (CRL 1445). IRAP mRNA was regulated in a time- and dose-dependent manner by IL-1 alpha, TNF-alpha, LPS, and PMA. Maximal induction of IRAP mRNA was observed between 8 and 16 h after stimulation with IL-1 alpha (1 U/ml), TNF-alpha (10 U/ml), LPS (50 ng/ml), and PMA (10 ng/ml). Their relative efficacy was as follows: PMA > LPS > IL-1 alpha > TNF-alpha. Potentiation was observed when fibroblasts were treated with IL-1 alpha plus basic fibroblast growth factor and IL-1 alpha plus platelet-derived growth factor-BB homodimer. Although LPS and PMA were the best inducers of IRAP mRNA, quantitation of the IRAP protein revealed that its synthesis and release were differentially regulated. Immunoprecipitation and SDS-PAGE of culture supernatant from LPS-treated cells and cell lysates of fibroblasts treated with LPS or PMA showed a single IRAP band with a molecular mass of approximately 22 kDa. Very little IRAP was detected in culture supernatants of cells treated with PMA. Quantitation of IRAP revealed that LPS induced the synthesis of secreted IRAP that was released, whereas the majority of the protein induced by PMA remained cell-associated. Reverse transcriptase-polymerase chain reaction amplification demonstrated that although LPS and PMA induced both transcripts, LPS preferentially induced secreted IRAP, whereas PMA differentially induced intracellular IRAP mRNA. Fibroblasts synthesize at least two different forms of IRAP depending on the inducing signal, and may regulate the inflammatory response by dampening the proinflammatory effects of IL-1 via a negative feedback mechanism with IRAP. The relative importance of fibroblast sIRAP vs intracellular IRAP in regulating the inflammatory response by the connective tissue remains to be determined.
白细胞介素-1受体拮抗剂蛋白(IRAP)是白细胞介素-1的竞争性抑制剂,主要由单核细胞合成。我们发现该分子也在人滑膜成纤维细胞和真皮成纤维细胞(CRL 1445)中表达。IRAP mRNA受白细胞介素-1α、肿瘤坏死因子-α、脂多糖(LPS)和佛波酯(PMA)的时间和剂量依赖性调节。在用白细胞介素-1α(1 U/ml)、肿瘤坏死因子-α(10 U/ml)、脂多糖(50 ng/ml)和佛波酯(10 ng/ml)刺激后8至16小时观察到IRAP mRNA的最大诱导。它们的相对效力如下:佛波酯>脂多糖>白细胞介素-1α>肿瘤坏死因子-α。当成纤维细胞用白细胞介素-1α加碱性成纤维细胞生长因子以及白细胞介素-1α加血小板衍生生长因子-BB同二聚体处理时观察到增强作用。尽管脂多糖和佛波酯是IRAP mRNA的最佳诱导剂,但IRAP蛋白的定量显示其合成和释放受到不同调节。对脂多糖处理细胞的培养上清液以及用脂多糖或佛波酯处理的成纤维细胞裂解物进行免疫沉淀和十二烷基硫酸钠-聚丙烯酰胺凝胶电泳显示一条分子量约为22 kDa的单一IRAP条带。在用佛波酯处理的细胞培养上清液中检测到的IRAP很少。IRAP的定量显示脂多糖诱导分泌型IRAP的合成并释放,而佛波酯诱导的大多数蛋白仍与细胞相关。逆转录聚合酶链反应扩增表明,尽管脂多糖和佛波酯都诱导两种转录本,但脂多糖优先诱导分泌型IRAP,而佛波酯则不同程度地诱导细胞内IRAP mRNA。成纤维细胞根据诱导信号合成至少两种不同形式的IRAP,并可能通过与IRAP的负反馈机制减弱白细胞介素-1的促炎作用来调节炎症反应。成纤维细胞分泌型IRAP与细胞内IRAP在调节结缔组织炎症反应中的相对重要性仍有待确定。